Press Releases

 Filter by Provider

In times of an immediate financial crunch, people often resort to liquidating their holdings. But selling assets can have negative repercussions on long-term financial goals and future returns.

Louisville, Colorado--(Newsfile Corp. - August 25, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF), a market leader in...

PureTech Health plc (LSE: PRTC) ("PureTech" or the "Company"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, is pleased to note that its Founded Entity Celea Therapeutics (“Celea”) today announced that it will deliver two presentations showcasing its deupirfenidone (LYT-100) program at the upcoming European Respiratory Society (ERS) Congress, taking place in Barcelona, Spain, from September 5-9, 2026. Deupirfenidone is an investigational therapy in Phase 3 development with the potential to serve as a new standard of care for the treatment of idiopathic pulmonary fibrosis (IPF).

Successful Limited Launch Demonstrates Demand for Innovative Pediatric-Specific Hip Plating Technology

Company adds $1.5 billion of incremental warehouse capacity and prices second AAA-rated ABS transaction, nearly 5x covered

BEIJING, Aug. 25, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced its unaudited financial results for the quarter ended June 30, 2026.

stc group, a leading digital enabler, concluded its third consecutive year as a Founding and Elite Partner of the Esports World Cup (EWC), supporting the tournament as it staged its first edition outside Saudi Arabia in Paris. The largest EWC to date brought together more than 2,000 professional players and 200 clubs from over 100 countries, competing across 25 tournaments and 24 game titles for a prize pool exceeding $75 million.

MALVERN, Pa., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present on its innovative modifier gene therapy platform at upcoming investor and industry conferences in September 2026.

Southfield, MI, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Sun Communities, Inc. (NYSE: SUI) (the “Company”), a real estate investment trust (“REIT”) that owns and operates, or has an interest in, manufactured housing (“MH”) and recreational vehicle (“RV”) communities (collectively, the “properties”), today announced that Robert A. (“Bob”) Garechana will join the Company as Executive Vice President and Chief Financial Officer (“CFO”), effective September 8, 2026, succeeding Fernando Castro-Caratini, who will transition to an advisory role with the company.

Vancouver, British Columbia--(Newsfile Corp. - August 25, 2026) - Jackpot Digital Inc. (TSXV: JJ) (OTCQB: JPOTF) (Frankfurt Stock Exchange: LVH3) (the "Company"...

NEWPORT BEACH, Calif., Aug. 25, 2026 (SEND2PRESS NEWSWIRE) -- Optimism, the platform for well-being, today announced that writer, podcaster, and three-time bestselling author Case Kenny has joined the company as its first Chief Optimist. Kenny will help ensure that Optimism's science-backed guidance reaches its audiences in a voice that actively builds optimism, and will lead new consumer programming, beginning with Mantra, launching September 2, 2026.

DENVER, CO - August 25, 2026 - Denver Laundry Service is expanding access to professional laundry pickup and delivery for residents and businesses throughout Denver. Designed for busy professionals, families, apartment and condo residents, Airbnb hosts, property managers, and local businesses, the service provides a convenient way to manage laundry without spending hours washing, drying, folding, or making trips to a laundromat.

Vancouver, British Columbia--(Newsfile Corp. - August 25, 2026) - Excalibur Metals Corp. (TSXV: EXCL) (OTCQB: EXCBF) ("Excalibur" or the "Company")...

Vancouver, British Columbia--(Newsfile Corp. - August 25, 2026) - Zodiac Gold Inc. (TSXV: ZAU) (OTCQB: ZAUIF) (FSE: K19) ("Zodiac Gold"...

Montreal, Quebec--(Newsfile Corp. - August 25, 2026) - Bullion Gold Discoveries Corp. (TSXV: BGD) ("Bullion" or the "Company") is pleased...

Kelowna, British Columbia--(Newsfile Corp. - August 25, 2026) - F3 Uranium Corp. (TSXV: FUU) (OTCQB: FUUFF) ("F3" or "the Company")...

Among the conditions, the Company must demonstrate compliance with the minimum bid price requirement by September 21, 2026 and the...

Infravision, the company transforming how power grids are built and maintained with drone-enabled technology, today announced the appointment of veteran transmission construction leader Paul Gillespie as Director, Transmission Solutions. Gillespie will support the global deployment of drone and robotic systems across overhead transmission construction.

Radiology Partners, Inc. (“RP”), the leading provider of technology and AI-enabled radiology services, today announced that it has entered into a definitive agreement to acquire Everlight Radiology (“Everlight”), a leading international teleradiology provider serving hospitals, health systems and imaging centers across the United Kingdom, Ireland, Australia, New Zealand and South Africa. The transaction is subject to customary regulatory approvals and closing conditions. Financial terms were not disclosed.

Auxia, the agentic marketing platform, today announced the launch of Auxia Agent Studio, a product where marketers engage AI agents to plan, build, and launch campaigns across a team's existing stack. Agent Studio gives marketing teams a shared foundation of business context, delegates manual execution to AI agents, and lets them coordinate work across the organization, turning every marketer into an AI-powered team.

Addionics, a pioneer in advanced battery architecture, today announces a new Battery Architecture for Low-Temperature Performance, a ground-breaking smart battery architecture designed to increase battery operations and charging capabilities at low temperatures. The new technology enhances the performance of electric vehicles, trucks, defense drones, and space and electric aviation in cold weather, where traditional lithium-ion batteries decline. Some of the benefits of the new architecture include extended mission capabilities, increased usability range, faster charging, and overall enhanced performance in low temperatures.

Capital Square, a leading sponsor of tax-advantaged real estate investments and an active developer and manager of housing communities nationwide, today announced that Phillip Jensen has joined the firm as senior vice president, national accounts, and will also oversee sales efforts in the Northwest territory comprised of California, Idaho, Montana, Oregon, Washington and Wyoming. In his new role, Jensen will work alongside Albert Thompson, senior vice president, national accounts, to build and strengthen strategic relationships with broker-dealers and registered investment advisers nationwide.

JOLT, the global digital out-of-home (DOOH) and EV charging network, has launched Spark Intelligence in the United States. The platform supports more than 4,750 digital screens in 34 states and 65 DMAs. Watch a 90-second overview of JOLT and Spark Intelligence.

Pipedrive, the easy and intelligent CRM for small and medium-sized businesses, today released a new report, “AI and humanity at work: How professionals are balancing efficiency and human connection”. The report examines how professionals across industries, employment types and age groups are navigating AI adoption and reveals a striking paradox: while AI is becoming part of everyday work for millions of people, most professionals surveyed still say it’s judgment, relationships and trust that determine whether they succeed, not technology.

Deep Fission, Inc. (Nasdaq: FISN) (“Deep Fission” or the “Company”), an advanced nuclear energy company developing small modular pressurized water reactors installed one mile underground, today announced the appointment of ShawnTrell Scales as Chief People Officer. She will lead the company's people strategy as Deep Fission aims to advance from first-of-a-kind demonstration to commercial deployment.

Redwire Corporation (NYSE: RDW), a global leader in aerospace and defense technology solutions, today announced a strategic investment in next‑generation phased array antenna technology to deliver faster, more resilient, and more scalable space‑based data networks for global warfighter communications. This strategic investment positions Redwire at the forefront of a rapidly expanding market where high‑capacity, low‑latency communication is essential for national security, civil, and commercial missions.

FutureProof Technologies, an AI-native property insurance MGA and Agency, today announced the appointment of Jonathan Mertz as Chief Business Officer. Mertz, a seasoned insurance executive with more than two decades of experience spanning insurance enterprise operations, growth strategy and M&A, will lead FutureProof's business development, strategic partnerships, and go-to-market efforts as the company scales toward building its AI-native full-stack property insurance carrier.

Kinaxis® Inc. (TSX:KXS), a global leader in AI-powered supply chain planning and orchestration, today announced that Ansaldo Energia, a global leader of power generation technology, has selected the Kinaxis Maestro™ platform to help orchestrate its complex supply chain in supporting one of the fastest-growing infrastructure markets in the world.

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced the publication of primary analysis results from the global Phase III HARMONi clinical trial in The Lancet Oncology. In HARMONi, ivonescimab in combination with platinum-doublet chemotherapy demonstrated a statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to placebo plus platinum-doublet chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) whose disease progressed following treatment with a third-generation EGFR tyrosine kinase inhibitor (TKI).

Today, Logitech (SIX: LOGN) (NASDAQ: LOGI) has supercharged its presence and environmental sensor, Logitech Spot, helping companies turn passive room data into action. By connecting Spot’s data stream directly into leading workplace management, AV control, and analytics platforms – including Appspace, Extron, Q-SYS, Planon, Robin, Spaceti, Utelogy, VergeSense, Xyte and Zoom – company leaders and employees can now benefit from truly responsive, automated workspaces.

Hyundai Translead today announced the addition of Range Zero Emissions to its authorized commercial vehicle dealer network, expanding customer access to Hyundai Motor's XCIENT Fuel Cell truck and further strengthening its commitment to advancing hydrogen mobility in North America.

SelectQuote, Inc. (NYSE: SLQT) reported consolidated revenue for the fourth quarter of fiscal year 2026 of $321.7 million compared to consolidated revenue for the fourth quarter of fiscal year 2025 of $345.1 million. Consolidated net loss for the fourth quarter of fiscal year 2026 was $16.8 million compared to consolidated net income for the fourth quarter of fiscal year 2025 of $12.9 million. Consolidated Adjusted EBITDA* for the fourth quarter of fiscal year 2026 was $11.9 million compared to consolidated Adjusted EBITDA* for the fourth quarter of fiscal year 2025 of $2.7 million. Consolidated cash used in operations during the fourth quarter of fiscal year 2026 was $3.3 million compared to $37.5 million used during the fourth quarter of fiscal year 2025.

Celea Therapeutics, Inc. ("Celea" or the "Company"), a clinical-stage biopharmaceutical company dedicated to advancing transformative treatments for people with serious respiratory diseases, today announced that the Company will deliver two presentations showcasing its deupirfenidone (LYT-100) program at the upcoming European Respiratory Society (ERS) Congress, taking place in Barcelona, Spain, from September 5-9, 2026. Deupirfenidone is an investigational therapy in Phase 3 development with the potential to serve as a new standard of care for the treatment of idiopathic pulmonary fibrosis (IPF).

PGT® Windows and Doors, America’s authority in high-performance windows and doors and part of the MITER Brands portfolio, is pleased to share that its WinGuard® impact-resistant product lines were recognized by Consumer Reports®, the most trusted independent testing resource in the nation, as the Top-Rated Storm Window for 2026.

TORONTO, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Xanadu Quantum Technologies Limited ("Xanadu"; NASDAQ/TSX: XNDU), a leading photonic quantum computing company, has announced the next phase of its collaboration with Mitsubishi Chemical, a major Japanese chemical manufacturer, to advance semiconductor fabrication technologies using quantum computing algorithms. This next phase is supported by national innovation programs from both the Canadian and Japanese governments, aiming to scale Xanadu and Mitsubishi’s previous work in simulating a vital process in next-generation semiconductor fabrication: extreme ultraviolet (EUV) lithography. Bringing together both Canadian and Japanese expertise in quantum computing and materials science, this collaboration underscores a shared commitment to driving global innovation in the semiconductor industry through quantum technologies.

CAMBRIDGE, Mass., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Parabilis Medicines (Nasdaq: PBLS), a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking historically undruggable targets, today announced the appointment of Craig L. Tendler, M.D., to its Board of Directors. Dr. Tendler previously led both clinical development and medical affairs for oncology at Johnson & Johnson. He has served as a scientific advisor to Parabilis Medicines, a role he will continue alongside his Board responsibilities. “We are delighted to welcome Craig to the Parabilis Board of Directors,” said Mathai Mammen, M.D., Ph.D., Chairman, CEO and President of Parabilis Medicines. “I have known Craig for many years and know the rigor, judgment and creativity he brings. His unparalleled experience guiding innovative medicines from clinical development and global approval through subsequent product adoption and medical affairs will be tremendously valuable to Parabilis as we continue to advance zolucatetide across multiple indications and build our broader pipeline of HeliconTM therapeutics. I consider Craig to be one of the most prolific oncology drug developers in our industry. He has a strategic mind and is driven by patient needs in all that he does.” “Throughout my career, I have seen the difference that opening new therapeutic avenues can make for patients,” said Dr. Tendler. “I am pleased to join the Board of Parabilis at this pivotal time and complement its efforts to translate clinical insights into strategies that accelerate the development and approval of potentially transformational therapies such as zolucatetide.” Dr. Tendler brings more than 30 years of experience in oncology drug development and medical affairs, including two decades at Johnson & Johnson, where he held leadership roles across clinical development, medical affairs and business development and most recently served as Global Head of Late-Stage Clinical Development and Global Medical Affairs for Oncology. During his tenure at J&J, he played a key role in securing more than 30 oncology regulatory approvals across prostate cancer (ZYTIGA®, AKEEGA® and ERLEADA®), hematologic malignancies (DARZALEX®, CARVYKTI®, TECVAYLI®, TALVEY®, IMBRUVICA®), lung cancer (RYBREVANT®) and bladder cancer (BALVERSA®), as well as 13 FDA Breakthrough Therapy designations and approvals for 15 New Molecular Entities (NMEs). He also worked closely with clinical and commercial teams to support the practical adoption of many of these practice-changing medicines through medical affairs data generation activities in collaboration with academic and community-based investigators. Dr. Tendler also played an integral role in securing major oncology business development transactions and collaborations, including J&J’s acquisitions of Cougar Biotechnology, Aragon Pharmaceuticals and Taris Biomedical and co-development partnerships with Legend Biotech, Pharmacyclics and Genmab.

BETHESDA, Md., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain” or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that Gene Mack, President and CEO, will participate in one-on-one meetings at the H.C. Wainwright 28th Annual Global Investment Conference, held September 14-16 in New York City, NY.

MINNEAPOLIS, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Range Zero Emissions, the leading multi-OEM EV dealership and distribution platform, today announced a strategic company transformation that includes the acquisition of Ethero Truck & Energy (West Coast operations), the consolidation of Ziegler Truck Group's zero-emissions business under the Range Zero Emissions brand, and a new commercial vehicle partnership with Hyundai Translead to provide sales, service, and aftermarket support for the XCIENT Fuel Cell Truck.

SAN FRANCISCO, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Fareon, a clinical-stage biophysics company pioneering novel therapies for brain disorders, brain injuries, and neurodevelopmental conditions, today announced that results of a clinical study evaluating its Fareon Restore™ biophysics platform in people with persistent, debilitating Long COVID brain fog will be presented at the International Society for Long COVID and Post-Acute Infection Syndromes (ISLC-PAIS) Annual Meeting, held August 26-29, 2026 in Amsterdam.

Hazy Jane, Wingman and Mackie’s Two Scoops Earn Gold and Scotland Country Winner Awards, with Punk IPA, Lost Lager, Black Heart and Mello Also Recognised Among the World’s Best Beers

Houston, Texas and Tuebingen, Germany, August 25, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and bispecifics, announced today that it has agreed to sell 12,945,916 ordinary shares at $8.69 per share and, in lieu of ordinary shares to certain investors, pre-funded warrants to purchase 4,315,304 ordinary shares at a purchase price of $8.689 per pre-funded warrant, which represents the per share offering price less the $0.001 per share exercise price for each pre-funded warrant, in an underwritten offering. The gross proceeds from the offering, before deducting the underwriting discount and offering expenses, are expected to be $150 million. The offering is expected to close on August 26, 2026, subject to customary closing conditions. In addition, Immatics has granted the underwriters a 30-day option to purchase up to 2,589,184 additional shares at the public offering price, less the underwriting discount.

MONTREAL, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Troilus Mining Corp. (TSX: TLG; OTCQX: CHXMF; FSE: CM5) (“Troilus” or the “Company”), is pleased to announce the selection of Metso Corporation (“Metso”) for the first phase of major process equipment procurement for the gold-copper Troilus Project in north-central Québec.

Vancouver, BC, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Trident Resources Corp. (TSXV: ROCK) (OTCQB: TRDTF) (Frankfurt: 6BP0) (“Trident” or the “Company”) is pleased to announce the commencement of an airborne magnetic and radiometric geophysical survey over the underexplored Reindeer Gold Project in the La Ronge Gold Belt (LRGB) of Northern Saskatchewan. The fixed-wing low level tight drape high resolution radiometric and aeromagnetic survey began on August 17th and will continue for the next few weeks.

Recognition Marks Informativ's Third Consecutive Year on the List

All clinical trial sites identified and CRO retained

RALEIGH, N.C., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging Holdings, Inc. (“Lumexa Imaging”) (Nasdaq: LMRI), one of the nation’s largest providers of outpatient imaging services, announced today that Caitlin Zulla, CEO, and Tony Martin, CFO, will participate in the following upcoming investor conferences:

ATLANTA, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the 2026 Jefferies Healthcare Services and Technology Conference in Nashville on September 15, 2026. Management will present at 4:10pm CST and will also host 1x1 investor meetings that same day. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investor Relations section of the Company’s website at https://ir.aveanna.com/. The online replay will be available for a limited time shortly following the call.

NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Lotus Technology Inc. (Nasdaq: LOT) (“Lotus Tech” or the “Company”), a leading global intelligent and luxury mobility provider, today announced that it completed the acquisition of 100% of the equity interests in Lotus Advance Technologies Sdn Bhd (“Lotus UK”) on August 21, 2026.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Biotech in the News: The Longview